ليست عنوان مقالات لاتين Neurochemical Effects of Nicotine on Albino Rat’s Brain Neuropathy complicating diffuse infiltrative lymphocytosis

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Neurochemical Effects of Nicotine on Albino Rat’s Brain

2

Neurochemical effects of sleep deprivation in the hippocampus of the pilocarpine-induced rat model of epilepsy

3

Neurochemical imbalances linked to sleep disorders

4

Neurochemical Insights Into COVID-19-related Anosmia: A Commentary Study

5

Neurochemical markers for schizophrenia, bipolar disorder, and major depression in postmortem brains

6

Neurochemical mechanisms for cancer anorexia

7

Neurochemical Modulating Effect of Boswellia serrata Roxb. ex Colebr: A Preclinical Research

8

Neurochemical parameters of the main neurotransmission systems in aging mice

9

Neurochemical Profile of 8-Hydroxy-2-(Di-N-propylamino) tetralin (8-OH-DPAT) Induced Hyperphagia in Sugar Rich Diet Treated Rats

10

Neurochemical regulation of sleep

11

Neurochip logic design and simulation of an integrated classifier Original Research Article

12

Neurocinema: A brief overview

13

Neurocircuitry Models of Posttraumatic Stress Disorder and Extinction: Human Neuroimaging Research—Past, Present, and Future

14

Neurocircuitry of limbic dysfunction in anorexia nervosa

15

Neurocognition of auditory sentence comprehension: event related fMRI reveals sensitivity to syntactic violations and task demands

16

Neurocognitive alterations in first degree relatives of suicide completers

17

Neurocognitive and clinical predictors of functional outcome in patients with schizophrenia and bipolar I disorder at one-year follow-up

18

Neurocognitive and neuroimaging correlates of pediatric traumatic brain injury: A diffusion tensor imaging (DTI) study

19

Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: A prospective 1 year follow-up study

20

Neurocognitive changes after carotid revascularization: A review of the current literature

21

Neurocognitive changes in chronic liver disease

22

Neurocognitive changes in depressed patients in psychodynamic psychotherapy, therapy with fluoxetine and combination therapy

23

Neurocognitive characteristics of DUI recidivists

24

Neurocognitive Complications after Off-Pump and On-Pump CABG

25

Neurocognitive Complications after Ventricular Neuroendoscopy: A Systematic Review

26

Neurocognitive Correlates of Anxiety Disorders in Children:: A Preliminary Report

27

Neurocognitive correlates of CVLT performance in an academically impaired sample

28

Neurocognitive correlates of processing food-related stimuli in a Go/No-go paradigm

29

Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia

30

Neurocognitive correlates of white matter quality in adolescent substance users

31

Neurocognitive Decline After Off-Pump Versus On-Pump Coronary Artery Bypass

32

Neurocognitive deficit following coronary artery bypass grafting: a prospective study of surgical patients and nonsurgical controls

33

Neurocognitive deficits and psychiatric disorders in a NSW prison population

34

Neurocognitive Deficits in Individuals at Ultra-High-Risk for Psychosis: An Overview of Systematic Reviews

35

Neurocognitive development of children with congenital unilateral brain lesion and epilepsy

36

Neurocognitive disability, stroke, and surgery: A role for neuroergonomics

37

Neurocognitive dysfunction in antidepressant-free, non-elderly patients with unipolar depression: Alerting and covert orienting of visuospatial attention

38

Neurocognitive Dysfunction in Head Injured Patients, Does It Reveal Various Outcomes in Both Sexes and Age-Groups?

39

Neurocognitive effects after brief pulse and ultrabrief pulse unilateral electroconvulsive therapy for major depression: A review

40

Neurocognitive Effects In School Age Children Following Lead Exposure In Early Childhood

41

Neurocognitive effects of atypical and conventional antipsychotic drugs in schizophrenia: A naturalistic 6-month follow-up study

42

Neurocognitive Effects of Phenobarbital Discontinuation in children

43

Neurocognitive effects of phenobarbital discontinuation in epileptic children

44

Neurocognitive effects of repetitive transcranial magnetic stimulation in severe major depression

45

Neurocognitive elements of antisocial behavior: Relevance of an orbitofrontal cortex account

46

Neurocognitive Function and Cerebral Emboli: Randomized Study of On-Pump Versus Off-Pump Coronary Artery Bypass Surgery

47

Neurocognitive function and quality of life in relation to hematocrit levels in chronic hemodialysis patients

48

Neurocognitive function in clinically stable men with bipolar I disorder or schizophrenia and normal control subjects

49

Neurocognitive Function of Children suffering from Acute Lymphoblastic Leukemia in Southern Iran

50

Neurocognitive functioning and improvement in quality of life following participation in cardiac rehabilitation

51

Neurocognitive Functioning as a Predictor for Silent Infarction in Children with Sickle Cell Disease

52

Neurocognitive Functioning in AD/HD, Predominantly Inattentive and Combined Subtypes

53

Neurocognitive Functioning in Patients Undergoing Coronary Artery Bypass Graft Surgery or Percutaneous Coronary Intervention: Evidence of Impairment Before Intervention Compared With Normal Controls

54

Neurocognitive functioning in subjects with eating disorders: the influence of neuroactive steroids

55

Neurocognitive functioning in the prodrome of mania—an exploratory study

56

Neurocognitive functioning in young high-risk offspring having a parent with bipolar I disorder

57

Neurocognitive functions after aortic arch repair with right brachial artery perfusion

58

Neurocognitive functions and behavioral profiles in children with nephropathic cystinosis

59

Neurocognitive impairment after acute coronary syndrome: Prevalence and characterization in a hospital-based cardiac rehabilitation program sample

60

Neurocognitive impairment does not predict treatment outcome in obsessive–compulsive disorder

61

Neurocognitive impairment in adolescent major depressive disorder: State vs. trait illness markers

62

Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects

63

Neurocognitive inertia

64

Neurocognitive insights into substance abuse

65

Neurocognitive Manifestations of SARSCoV2: A Narrative Review of Mechanisms

66

Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study

67

Neurocognitive markers of psychosis in bipolar disorder: A meta-analytic study

68

Neurocognitive mechanisms of anxiety: an integrative account

69

Neurocognitive mechanisms of cognitive control: The role of prefrontal cortex in action selection, response inhibition, performance monitoring, and reward-based learning

70

Neurocognitive mechanisms underlying the experience of flow

71

Neurocognitive outcome after retrograde cerebral perfusion

72

Neurocognitive Outcomes 3 Years After Coronary Artery Bypass Graft Surgery: A Controlled Study

73

Neurocognitive outcomes following pediatric brain injury: A developmental approach

74

Neurocognitive Outcomes in Off-Pump Versus On-Pump Bypass Surgery: A Randomized Controlled Trial

75

Neurocognitive Outcomes of Off-Pump Versus On-Pump Coronary Artery Bypass: A Prospective Randomized Controlled Trial

76

Neurocognitive Performance in Children with ADHD and OCD

77

Neurocognitive performance using the Windows spaceflight cognitive assessment tool (WinSCAT) in human spaceflight simulations

78

Neurocognitive Profile in Adolescents with Early-Onset Schizophrenia: Clinical Correlates

79

Neurocognitive profile of children with Attention Deficit Hyperactivity Disorders (ADHD): A comparison between subtypes

80

Neurocognitive Profile of Children With Reading Disability in Kannada

81

Neurocognitive screening in Latinos: A comparison of the cross-cultural cognitive examination and the mini-mental state examination

82

Neurocomputational models of the remote effects of focal brain damage

83

Neurocomputing in Civil Infrastructure

84

Neurocontrol of a ball mill grinding circuit using evolutionary reinforcement learning

85

Neurocontrol of an aircraft: Application to windshear

86

Neuro-control of cable vibration using semi-active magneto-rheological dampers

87

Neuro-control of fixed offshore structures under earthquake

88

Neurocontrol of nonlinear systems via local memory neurons

89

Neurocontrol of Pressurized Water Reactors in Load-Follow Operations

90

Neurocontrol: A literature survey

91

Neurocontrol: Recent advances and links with the human brain

92

Neuro-controller design for nonlinear fighter aircraft maneuver using fully tuned RBF networks

93

Neuro-controller for reducing cyclic variation in lean combustion spark ignition engines

94

Neurocritical Care Unit Bed Allocation: Optimization Based on Prioritization Using Simulation

95

Neurocutaneous melanosis in an adult patient with diffuse leptomeningeal melanosis and a rapidly deteriorating course: Case report and review of the literature

96

Neurocutaneous syndromes: Behavioral features

97

Neurocycle Mind-management Approach: Effect on the Resiliency and Wellbeing of Female University Students

98

Neurocysticercosis - Islam and Other Religions

99

Neurocysticercosis and Oncogenesis

100

Neurocysticercosis immunodiagnosis using Taenia solium cysticerci crude soluble extract, excretory secretory and lower molecular mass antigens in serum and urine samples of Indian children

101

Neurocysticercosis in central Saudi Arabia

102

Neurocysticercosis in Europe: Still a public health concern not only for imported cases

103

Neurocysticercosis, mesial temporal lobe epilepsy, and hippocampal sclerosis: an association largely ignored

104

Neurocysticercosis: Changes after 25 Years of Medical Therapy

105

Neurocysticercosis: Changes After 25 Years of Medical Therapy

106

Neurocysticercosis: manifestations, diagnosis and treatment

107

Neurocysticercosis: manifestations, diagnosis and treatment

108

Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas

109

Neurocysticercosis: updated concepts about an old disease

110

Neurodegeneration and diabetes: UK nationwide study of Wolfram (DIDMOAD) syndrome

111

Neurodegeneration as a mechanisms underlying ENS dysfunction: Translational concepts

112

Neurodegeneration in hereditary nucleotide repair disorders

113

Neurodegeneration with Brain Iron Accumulation: An Overview

114

Neurodegeneration, parkinsonian syndromes and autonomic failure

115

Neurodegeneration: a failure of neuroregeneration?

116

Neurodegeneration: new clues on inclusions Review Article

117

Neurodegenerations in domestic animals: a new way forward

118

Neurodegenerative aspects of protein aggregation

119

Neurodegenerative changes including altered tau phosphorylation and neurofilament immunoreactivity in mice transgenic for the serine/threonine kinase mos

120

NEURODEGENERATIVE DEMENTIA AND PARKINSONISM

121

Neurodegenerative diseases and oxidative stress

122

Neurodegenerative diseases and risk factors: A literature review

123

Neurodegenerative diseases in domestic animals: A comparative review

124

Neurodegenerative diseases: insights into pathogenic mechanisms from atherosclerosis

125

Neurodegenerative disorders, bullous pemphigoid and psoriasis: a comparative study in ethnic Poles indicates that Parkinson’s disease is more relevant to bullous pemphigoid

126

Neurodevelopment and the Transition from Schizophrenia Prodrome to Schizophrenia: Research Imperatives

127

Neurodevelopment of surviving infants at age two years, with a birthweight less than 2000 g and cared for in neonatal intensive care units (NICU)—results from a population based longitudinal study in Taiwan

128

Neurodevelopment outcomes and maternal methylmercury exposure: Breastfeeding is part of the solution not the problem

129

Neurodevelopment, Growth, and Viral Load in HIV-Infected Infants

130

Neurodevelopmental consequences of very preterm births

131

Neurodevelopmental course in pediatric onset progressive calcification of the basal ganglion: A case report

132

Neurodevelopmental damage after prenatal infection: Role of oxidative stress in the fetal brain

133

Neurodevelopmental differences in verbal fluency in children

134

Neurodevelopmental disabilities and special care of 5-year-old children born before 33 weeks of gestation (the EPIPAGE study): a longitudinal cohort study

135

Neurodevelopmental Disorders

136

Neurodevelopmental Disorders among Indian Children: Needs Attention

137

Neurodevelopmental effects of decabromodiphenyl ether (BDE-209) and implications for the Reference Dose

138

Neurodevelopmental Follow Up After Therapeutic Hypothermia for Perinatal Asphyxia

139

Neurodevelopmental integrity and zahavian bioacoustics

140

Neurodevelopmental Investigations among Methylmercury-Exposed Children in French Guiana

141

Neurodevelopmental outcome after laser therapy for twin-twin transfusion syndrome

142

Neurodevelopmental outcome at age two years amongst very low birth weight infants: results from a district general hospital

143

Neurodevelopmental outcome of congenital hypothyroidism in children between 1-5 years of age

144

Neurodevelopmental Outcome of Patients With Agenesis of Corpus Callosum

145

Neurodevelopmental outcome of premature infants after antenatal phenobarbital exposure

146

NEURODEVELOPMENTAL OUTCOME ONE YEAR AFTER EARLY VERSUS LATE SELECTIVE SURFACTANT TREATMENT

147

Neurodevelopmental outcome related to cerebral risk factors in children after neonatal arterial switch operation

148

Neurodevelopmental Outcomes of Infants with Benign Enlargement of the Subarachnoid Space

149

Neurodevelopmental outcomes of infants with birth weights of less than 1000 g: comparison between periods before and after the introduction of surfactant

150

Neurodevelopmental Outcomes of Seychellois Children from the Pilot Cohort at 108 Months Following Prenatal Exposure to Methylmercury from a Maternal Fish Diet,

151

Neurodevelopmental patterns of visual P3b in association with familial risk for alcohol dependence and childhood diagnosis

152

Neurodevelopmental Status in 3 - 5 Years-Old Children with a History of Congenital and Acquired Hypothyroidism

153

Neurodevelopmental Status of Infants Conceived Assisted Reproductive Techniques in Royan Institute

154

Neurodevelopmental Toxic Effects of Food Additives Used in Energy Drinks on Developing Rats

155

Neurodevelopmental toxicity of methylmercury: Laboratory animal data and their contribution to human risk assessment

156

Neurodevelopmental, immunological and endocrinological indices of perinatal human exposure to PCBs and dioxins

157

Neurodisruption of selective attention: insights and implications

158

Neuro-dynamic trading methods

159

Neurodynamical amplification of perceptual signals via system-size resonance

160

Neuroecology and psychological modularity

161

Neuroeconomics and the metastable brain

162

Neuroeconomics: cross-currents in research on decision-making

163

Neuroeconomics: Present and future

164

Neuroelectric and behavioral indices of interference control during acute cycling

165

Neuroelectric correlates of response production and inhibition in individuals at risk to develop alcoholism

166

Neuroelectrical signs of selective attention to color in boys with attention-deficit hyperactivity disorder

167

Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis?

168

Neuroendocrine activation in heart failure is modified by endurance exercise training

169

Neuroendocrine Adenoma of Middle Ear Causing Acute Onset Facial Palsy- A Rare Case Report

170

Neuroendocrine aging in birds: Comparing lifespan differences and conserved mechanisms

171

Neuroendocrine and behavioral interaction in exposure treatment of phobic avoidance

172

Neuroendocrine and biologic features of primary tumors and tissue in pulmonary large cell carcinomas

173

Neuroendocrine and Clinical Characteristics of Major Depressed Patients Exhibiting Sleep-Onset REM

174

Neuroendocrine aspects of chronic fatigue syndrome: a commentary

175

Neuro-endocrine biomarkers of pollution-induced stress in marine invertebrates q

176

Neuroendocrine biomarkers, allostatic load, and the challenge of measurement: A commentary on Gersten

177

Neuroendocrine biomarkers, social relations, and the cumulative costs of stress in Taiwan

178

Neuroendocrine Cancer of Rectum Metastasizing to Ovary

179

Neuroendocrine carcinoma (carcinoid) of the thymus associated with Cushing’s syndrome

180

Neuroendocrine carcinoma associated with X-linked hyper-immunoglobulin M syndrome: Report of four cases and review of the literature

181

NEUROENDOCRINE CARCINOMA OF OVARY IN ASSOCIATION WITH MUCINOUS CYSTADENOMA

182

Neuroendocrine carcinoma of the ovotestis: A case report and review of literatures

183

Neuroendocrine Carcinoma of the Stomach; A Case Report

184

Neuroendocrine carcinoma of unknown primary: A systematic review of the literature and a comparative study with other neuroendocrine tumors

185

Neuroendocrine Carcinomas of the Stomach: Computed Tomography and Pathologic Findings in 32 Patients

186

Neuroendocrine cells in the vestibular glands of the genital tract of cows and pigs

187

Neuroendocrine changes in systemic lupus erythematosus and Sjögrenʹs syndrome

188

Neuroendocrine Consequences of Prenatal Androgen Exposure in the Female Rat: Absence of Luteinizing Hormone Surges, Suppression of Progesterone Receptor Gene Expression, and Acceleration of the Gonadotropin-Releasing Hormone Pulse Generator

189

Neuroendocrine correlates of chronic fatigue syndrome: A brief review

190

Neuro-endocrine correlates of ovarian development and egg-laying behaviors in the primitively eusocial wasp (Polistes chinensis)

191

Neuroendocrine differentiated carcinomas of the breast: a distinct entity

192

Neuroendocrine disruption and health effects in Elliptio complanata mussels exposed to aeration lagoons for wastewater treatment Original Research Article

193

Neuroendocrine disruption in Mya arenaria clams during gametogenesis at sites under pollution stress

194

Neuroendocrine evidence for dopaminergic actions of hypericum extract (LI 160) in healthy volunteers

195

Neuroendocrine facets of human puberty

196

Neuroendocrine factors affecting the steady-state levels of early trypsin mRNA in Aedes aegypti

197

Neuroendocrine factors alter host defense by modulating immune function

198

Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network

199

Neuroendocrine immune mechanisms in rheumatic diseases

200

Neuroendocrine immune responses to inflammation: the concept of the neuroendocrine immune loop

201

Neuroendocrine Influences and Repercussions of the Menopause

202

Neuroendocrine insights from the laboratory to the clinic

203

Neuroendocrine interactions in the immune system

204

Neuroendocrine involvement in aging: Evidence from studies of reproductive aging and caloric restriction

205

Neuroendocrine involvement in the aging: Evidence from studies of reproductive aging and caloric restriction

206

Neuroendocrine mechanisms for immune system regulation during stress in fish

207

Neuroendocrine mechanisms in fibromyalgia–chronic fatigue

208

Neuroendocrine regulation of gonadotropins in the male and the female

209

Neuroendocrine regulation of rearing behavior in the native Thai hen

210

Neuroendocrine regulation of seasonal morph development in a bivoltine race (Daizo) of the silkmoth, Bombyx mori L.

211

Neuroendocrine response to antipsychotics: effects of drug type and gender

212

Neuroendocrine responses to d-fenfluramine and insulin-induced hypoglycemia in chronic fatigue syndrome

213

Neuroendocrine secretory protein 55 (NESP55) immunoreactivity in male and female rat superior cervical ganglion and other sympathetic ganglia

214

Neuroendocrine stress response and hyperglycemia in children undergoing laparoscopic surgery: a comparative study between remifentanil infusion and fentanyl boluses during sevoflurane-based anesthesia

215

Neuroendocrine Study of Serotonin Function in Female Borderline Personality Disorder Patients: A Pilot Study

216

Neuroendocrine Tumor of the Gallbladder

217

Neuroendocrine tumors (carcinoid) of the thymic gland

218

Neuroendocrine tumors and conotruncal cardiac defects

219

Neuroendocrine tumors of the lung and octreotide scintigraphy

220

Neuroendocrine tumors of the lung and octreotide scintigraphy: reply

221

Neuroendocrine tumors of the thymus: a clinicopathological and prognostic study

222

Neuroendocrine tumours (carcinoids) of the appendix

223

Neuroendocrine tumours in various organ systems in a ten-year period

224

Neuroendocrine tumours: clinical presentation and management of localized disease

225

Neuroendocrine vs. Paracrine Control of Follicle-Stimulating Hormone

226

Neuroendocrine, Cognitive and Structural Imaging Characteristics of Women on Longterm Sickleave with Job Stress–Induced Depression

227

Neuroendocrine, polysomnographic and psychometric observations in healthy subjects at high familial risk for affective disorders: the current state of the ‘Munich vulnerability study’

228

Neuroendocrine–immune interactions in fish: a role for interleukin-1

229

Neuroendocrine–immune interactions in fish: a role for interleukin-1

230

Neuroendocrine-Induced Synthesis of Bone Marrow-Derived Cytokines with Inflammatory Immunomodulating Properties

231

Neuroendocrine-mediated alteration of CD8+ T cell and microglia immune function during the development of stress-induced herpes simplex virus type-1 (HSV-1) encephalitis

232

Neuroepidemiology not only for neuroepidemiologists

233

Neuroepithelial Cells Supply an Initial Transient Wave of MSC Differentiation

234

Neuroepithelial Stem Cell Proliferation Requires LIS1 for Precise Spindle Orientation and Symmetric Division

235

Neuro-estimator based GMC control of a batch reactive distillation

236

Neuroet: An easy-to-use artificial neural network for ecological and biological modeling

237

Neuroet: An easy-to-use artificial neural network for ecological and biological modeling

238

Neuroethical Theories

239

Neuroethics, reductionism and dualism

240

Neuroethics: A Moral Approach Towards Neuroscience Research

241

Neuroethics: An emerging new discipline in the study of brain and cognition

242

Neuroethics: the practical and the philosophical

243

Neuroethics; Neuroscience for Ethics and/or Ethics for Neuroscience New Challenge for Third Millennium

244

Neuroethological study of status epilepticus induced by systemic pilocarpine in Wistar audiogenic rats (WAR strain)

245

Neuroethology application for the study of human temporal lobe epilepsy: From basic to applied sciences

246

Neuro-evolutionary approach applied for optimizing the PEMFC performance

247

Neuro-evolutionary optimization methodology applied to the synthesis process of ash based adsorbents

248

Neurofascial Dextrose Prolotherapy for Managing Chronic Ankle Ligament Injury

249

Neurofeedback and epilepsy

250

Neurofeedback Effect on Perceptual-Motor Skills of Children with ADHD

251

Neurofeedback provides a better theta-rical performance

252

Neurofeedback Training Versus Perceptual-motor Exercises Interventions in Visual Attention for Children With Attention-Deficit/Hyperactivity Disorder: A Randomized Controlled Trial

253

Neurofeedback treatment of pseudoseizure disorder

254

Neuroferritinopathy: a neurodegenerative disorder associated with L-ferritin mutation

255

Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration

256

Neurofibrillary changes of the Alzheimer type in very elderly individuals: Neither inevitable nor benign: Commentary on “No disease in the brain of a 115-year-old woman”

257

Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology

258

Neurofibrillary pathology — correlation with hippocampal formation atrophy in Alzheimer disease

259

Neurofibrillary tangle-associated alteration of stathmin in Alzheimerʹs disease

260

Neurofibrillary tangles and plaques are not accompanied by white matter pathology in aged triple transgenic-Alzheimer disease mice

261

Neurofibroma of the breast in a boy with neurofibromatosis type 1

262

Neurofibroma of the Esophagus

263

Neurofibroma of the Sciatic Nerve with Neurofibromatosis Type 1

264

Neurofibroma with Bone Destruction Masquerading Extracranial Meningioma

265

Neurofibromas as bilateral cystic chest wall swellings

266

Neurofibromatosis 1 and neurofibromatosis 2: a twenty first century perspective

267

Neurofibromatosis 1 presenting as a rare widespread neurofibromas with cord compression

268

Neurofibromatosis 2 gene in human colorectal cancer

269

Neurofibromatosis 2 Phenotypes and Germ-Line NF2 Mutations Determined by an RNA Mismatch Method and Loss of Heterozygosity Analysis in NF2 Schwannomas

270

Neurofibromatosis of the Esophagus

271

Neurofibromatosis Presenting as Painless Clitoromegaly

272

Neurofibromatosis type 1 and hyperparathyroidism. Case report

273

Neurofibromatosis Type 1 and Type 2: review of the central nervous system and related structures

274

Neurofibromatosis type 1 with pregnancy-associated renovascular hypertension and the syndrome of hemolysis, elevated liver enzymes, and low platelets, ,

275

Neurofibromatosis type I (von Recklinghausen’s disease): A family case report and literature review

276

Neurofibromatosis with Bilateral Renal Artery Stenosis and End Stage Renal Disease: Case Report

277

Neurofibromin and its inactivation of Ras are prerequisites for osteoblast functioning

278

Neurofibromin Regulation of ERK Signaling Modulates GABA Release and Learning

279

Neurofibrosarcoma of the duodenum

280

Neurofilament expression in the rat brain after cerebral infarction: effect of age

281

Neurofilament heavy chain gene polymorphism and risk of multiple sclerosis

282

Neurofilament light chain gene polymorphism and risk of multiple sclerosis in Iranian patients

283

Neurofilament M mRNA is Expressed in Conduction System Myocytes of the Developing and Adult Rabbit Heart,

284

Neuro-flow dynamics and the learning processes

285

Neurofolicullar hamartoma presenting as a rare adnexal neoplasm in association with basal cell carcinoma

286

Neurofunctional correlates of long-term arsenic exposure in humans

287

Neurofunctional correlates of personality traits in relapsing-remitting multiple sclerosis: An fMRI study

288

Neuro-fuzzy adaptive control based on dynamic inversion for robotic manipulators

289

NeuroFuzzy adaptive modelling and control : By Martin Brown and Chris Harris. Prentice-Hall, Englewood Cliffs, NJ (1994). IBSN 0-13-134453-6

290

Neuro-fuzzy and genetic algorithm in multiple response optimization

291

Neuro-fuzzy and neural network systems for air quality control

292

Neuro-fuzzy and neural network techniques for forecasting sea level in Darwin Harbor, Australia

293

Neuro-fuzzy approach for online message scheduling

294

Neuro-fuzzy approach for online message scheduling

295

Neuro-fuzzy approach to adaptive digital predistortion

296

Neurofuzzy approach to process parameter selection for friction surfacing applications

297

Neuro-fuzzy approach to processing inputs with missing values in pattern recognition problems Original Research Article

298

Neuro-fuzzy approach to real-time transient stability prediction based on synchronized phasor measurements

299

Neuro-fuzzy approach versus rough-set inspired methodology for intelligent decision support

300

Neuro-Fuzzy Approaches for Sanitary Sewer Pipeline Condition Assessment

301

Neuro-fuzzy ART-based document management system: application to mail distribution ، digital libraries

302

Neuro-Fuzzy Based Algorithm for Online Dynamic Voltage Stability Status Prediction Using Wide-Area Phasor Measurements

303

Neuro-fuzzy based constitutive modeling of undrained response of Leighton Buzzard Sand mixtures

304

Neuro-Fuzzy Based Performance Evaluation of Shunt Motor

305

Neuro-fuzzy based time-delay estimation using DCT coefficients

306

Neuro-fuzzy chip to handle complex tasks with analog performance

307

Neurofuzzy classification and rule generation of modes of radiowave propagation

308

Neuro-fuzzy closed-loop control of depth of anaesthesia

309

Neuro-fuzzy clustering of radiographic tibia image data using type 2 fuzzy sets

310

Neurofuzzy cognitive maps with adaptive B-splines

311

Neuro-fuzzy control for autonomous wind–diesel systems using biomass

312

Neurofuzzy control of a low-temperature desulphurization plant

313

Neuro-Fuzzy Control of a Robotic Exoskeleton With EMG Signals

314

Neuro-fuzzy control of bilateral teleoperation system using FPGA

315

Neurofuzzy control of modular and reconfigurable robots

316

Neuro-Fuzzy Control of Railcar Vibrations Using Semiactive Dampers

317

Neuro-fuzzy control of underwater vehicle-manipulator systems

318

Neuro-fuzzy controller for gas turbine in biomass-based electric power plant

319

Neurofuzzy design and model construction of nonlinear dynamical processes from data

320

Neuro-fuzzy dynamic model with Kalman filter to forecast irradiance and temperature for solar energy systems

321

Neuro-Fuzzy Estimation in Spatial Statistics

322

Neuro-Fuzzy Expert System for evaluating the performance of Distributed Software System Architecture

323

Neuro-fuzzy ID3: a method of inducing fuzzy decision trees with linear programming for maximizing entropy and an algebraic method for incremental learning

324

Neurofuzzy Inverse Jacobian Mapping for Multi-Finger Robot Hand Control

325

Neuro-fuzzy inverse model control structure of robotic manipulators utilized for physiotherapy applications

326

Neuro-fuzzy knowledge processing in intelligent learning environments for improved student diagnosis

327

Neuro-Fuzzy Logic Model for Evaluating Water Content of Sandy Soils

328

Neuro-fuzzy MIMO nonlinear control for ceramic roller kiln

329

Neuro-fuzzy mixture of experts network parallel learning and model construction algorithms

330

Neuro-fuzzy model of hybrid semi-active base isolation system with FPS bearings and an MR damper

331

Neuro-fuzzy Model-based Control

332

Neurofuzzy model-based predictive control of weld fusion zone geometry

333

Neuro-fuzzy modeling based genetic algorithms for identification of geochemical anomalies in mining geochemistry

334

Neuro-fuzzy modeling of rotation capacity of wide flange beams

335

Neuro-fuzzy modeling to adsorptive performance of magnetic chitosan nanocomposite

336

Neuro-fuzzy Modelling and Experimental Study of the Physiological Comfort of Green Cotton Fabric Based on Yarn Properties

337

Neuro-fuzzy modelling of power plant flue-gas emissions

338

Neuro-fuzzy network approach for modeling submicron MOSFETs: application to MOSFET subcircuit simulation

339

Neuro-fuzzy network for flavor recognition and classification

340

Neuro-fuzzy network for the classification of buried pipe defects

341

Neurofuzzy network model construction using Bezier-Bernstein polynomial functions

342

Neurofuzzy network modelling ، control of steam pressure in 300 MW steam-boiler system

343

Neuro-fuzzy networks ، their application to fault detection of dynamical systems

344

Neuro-fuzzy networks for voltage security monitoring based on synchronized phasor measurements

345

Neuro-fuzzy pattern classification for fault diagnosis in nuclear components

346

Neuro-fuzzy reasoning for occluded object recognition

347

Neuro-fuzzy relational systems for nonlinear approximation and prediction Original Research Article

348

Neuro-fuzzy river ice breakup forecasting system

349

Neuro-Fuzzy Sensor Fault Diagnosis of an Induction Motor

350

Neuro-fuzzy Sliding Mode Controller Based on a Brushless Doubly Fed Induction Generator

351

Neuro-fuzzy soft-switching hybrid filter for impulsive noisy environments

352

Neuro-fuzzy speed control of traveling-wave type ultrasonic motor drive using frequency and phase modulation

353

Neuro-fuzzy speed tracking control of traveling-wave ultrasonic motor drives using direct pulsewidth modulation

354

Neurofuzzy state identification using prefiltering

355

Neuro-fuzzy synergism to the intelligent system for edge detection and enhancement

356

Neuro-fuzzy system in partitioned client-side Web cache

357

Neuro-fuzzy system to predict permeability and porosity from well log data: A case study of Hassi R׳Mel gas field, Algeria

358

Neuro-fuzzy system with high-speed low-power analog blocks

359

Neuro-fuzzy system with learning tolerant to imprecision

360

Neuro-fuzzy systems for diagnosis

361

Neuro-fuzzy systems for function approximation

362

Neuro-fuzzy techniques for traffic control

363

Neuro-fuzzy TSK network for calibration of semiconductor sensor array for gas measurements

364

Neuro-fuzzy uncertainty de-coupling: a multiple-model paradigm for fault detection and isolation

365

Neuro-Fuzzy-Based Solar Cell Model

366

Neurofuzzy-model-following control of MIMO nonlinear systems

367

Neurogastroenterology: imaging of the sensory and motor control of the GI tract

368

Neurogenesis and depression: etiology or epiphenomenon?

369

Neurogenesis and Helplessness Are Mediated by Controllability in Males But Not in Females

370

Neurogenesis and neural stem cells in the dorsal vagal complex of adult rat brain: New vistas about autonomic regulations—a review

371

Neurogenesis in adulthood: a possible role in learning

372

Neurogenesis in gerbil hippocampus following brain ischemia: Focus on the involvement of metalloproteinases

373

Neurogenesis interferes with the retrieval of remote memories: Forgetting in neurocomputational terms

374

Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt

375

Neuro-genetic approach for optimisation of the spectrophotometric catalytic determination of cobalt Original Research Article

376

Neuro-genetic approach to multidimensional fuzzy reasoning for pattern classification

377

Neuro-genetic multioptimization of the determination of polychlorinated biphenyl congeners in human milk by headspace solid phase microextraction coupled to gas chromatography with electron capture detection Original Research Article

378

Neuro-genetic non-invasive temperature estimation: Intensity and spatial prediction

379

Neuro-genetic PID autotuning: time invariant case Original Research Article

380

Neuro-genetic prediction of software development effort

381

Neurogenetics study was unethical, says NNI report

382

Neurogenic and non-neurogenic mechanisms in response of rat distal colon muscle to dextran sulphate sodium treatment

383

Neurogenic cardiac damage and sudden death

384

Neurogenic cells in human amniotic fluid

385

Neurogenic claudication by epidural lipomatosis: a case report and review of literature

386

Neurogenic cluttering

387

Neurogenic Communication Disorders: a Functional Approach, Edited by L.E. Worrall, C.M. Frattali. New York/Stuttgart, Thieme 2000. TNY ISBN 0-96577-868-X; GTV ISBN 3-13-124471-2

388

Neurogenic essential hypertension revisited: the case for increased clinical and research attention

389

Neurogenic factors in hypertension caused by renal injury

390

Neurogenic failures of the external urethral sphincter closure and relaxation; a videourodynamic study

391

Neurogenic induction of human dental pulp derived stem cells by hanging drop technique, basic fibroblast growth factor, and SHH factors

392

Neurogenic myocardial dysfunction related to pulsatile compression of medulla by aneurysm

393

Neurogenic pulmonary oedema and enterovirus 71 encephalomyelitis

394

Neurogenic ST depression in stroke

395

Neurogenic stunned myocardium in a patient with metastatic brain tumors

396

Neurogenic stuttering versus developmental stuttering: An observer judgement study

397

Neurogenic tumors of the mediastinum originated from the vagus nerve

398

Neurogenic Vocal Fold Motion Impairment After Routine Intubation for Tonsillectomy in a Pediatric Patient

399

Neurogenin Promotes Neurogenesis and Inhibits Glial Differentiation by Independent Mechanisms

400

Neurogenins in brain development and disease: An overview

401

Neurogenomics—a capital investment?

402

Neuroglial response after induction of experimental allergic encephalomyelitis in susceptible and resistant rat strains

403

Neuroglial-mediated immunoinflammatory responses in Alzheimerʹs disease: Complement activation and therapeutic approaches

404

Neuroglobin and Prion Cellular Localization: Investigation of a Potential Interaction

405

Neuroglobin as a Neuroprotective in Neonates with Hypoxic Ischemic Encephalopathy

406

Neuroglobin might protect brain cells during stroke

407

Neuroglobin protects PC12 cells against β-amyloid-induced cell injury

408

Neuroglycopenic and other symptoms in patients with insulinomas

409

Neurographic assessment of lesions of single proper digital nerves

410

Neurohealth Properties of Hericium erinaceus Mycelia Enriched with Erinacines

411

Neurohormonal activation and diagnostic value of cardiac peptides in patients with suspected mild heart failure

412

Neurohormonal activation and left ventricular ejection fraction in patients with suspected myocardial ischemia

413

Neurohormonal activation in patients with right ventricular failure from pulmonary hypertension: Relation to hemodynamic variables and endothelin levels

414

Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension

415

Neurohormonal activation in severe heart failure: Relations to patient death and the effect of treatment with flosequinan

416

Neurohormonal activation rapidly decreases after intravenous therapy withdiuretics and vasodilators for class IV heart failure

417

Neurohormonal activity and left ventricular geometry in patients with essential arterial hypertension, , ,

418

Neurohormonal and clinical responses to high- versus low-dose enalapril therapy in chronic heart failure

419

Neurohormonal and dietary influences on hippocampal-dependent inhibitory controls of food intake

420

Neurohormonal blockade in chronic heart failure: How much is enough? can there be too much?

421

Neurohormonal changes in medical students during academic stress

422

Neurohormonal factors in the development of catabolic/anabolic imbalance and cachexia

423

Neurohormonal Inhibition in Heart Failure: Insights from Recent Clinical Trials

424

Neurohormonal modulation in cardiovascular disease

425

Neurohormonal perturbations in fibromyalgia

426

Neurohormonal prediction of mortality following admission for decompensated heart failure

427

Neurohormonal Response to Head-Up Tilt and Its Role in Vasovagal Syncope

428

Neurohormonal responses during positive pressure mechanical ventilation

429

Neurohormonal, Structural, and Functional Recovery Pattern After Premature Ventricular Complex Ablation Is Independent of Structural Heart Disease Status in Patients With Depressed Left Ventricular Ejection Fraction: A Prospective Multicenter Study

430

Neurohormones and oxidative stress in nonischemic cardiomyopathy: relationship to survival and the effect of treatment with amlodipine

431

Neurohormones as markers of right- and left-sided cardiac dimensions and function in patients with untreated chronic heart failure

432

Neurohumoral activations in congestive heart failure: Correlations with cardiac function, heart rate variability, and baroreceptor sensitivity,

433

Neurohumoral Cardiovascular Responses to Alcohol and Their Modulation by Peroral Fluid

434

Neurohumoral characteristics of older hypertensive patients with abnormal nocturnal blood pressure dipping

435

Neurohumoral measurements as indicators of bong-terns prognosis after acute myocardial infarction

436

Neurohumoral regulation in ischemia-induced heart failure: Role of the forebrain

437

Neurohumoral variability in left ventricular dysfunction

438

Neuro-hypnotism: Prospects for hypnosis and neuroscience

439

Neurohypophyseal peptides in aging and Alzheimer’s disease

440

Neuro-imagerie et états de stress post-traumatiques

441

Neuroimages of disseminated neurotuberculosis: Report of one case

442

Neuroimaging – Chance effects and unintended consequences

443

Neuroimaging and Attention-Deficit/Hyperactivity Disorder in the 21st Century: What to Consider and How to Proceed

444

Neuroimaging and early Alzheimerʹs disease

445

Neuroimaging and neuroenergetics: Brain activations as information-driven reorganization of energy flows

446

Neuroimaging correlates of anxiety after pediatric traumatic brain injury

447

Neuroimaging Evaluation for First Attack of Unprovoked Nonfebrile Seizure in Pediatrics: When to Order?

448

NEUROIMAGING FINDING OF ORGANIC ACADEMIA IN CHILDREN

449

Neuroimaging Findings in First Unprovoked Seizures: A Multicentric Study in Tehran

450

Neuroimaging findings in frontotemporal lobar degeneration spectrum of disorders

451

Neuroimaging in bipolar disorder: what have we learned?

452

Neuroimaging in borderline personality disorder

453

Neuroimaging in Cerebral Palsy – Report from North India

454

NEUROIMAGING IN CHILDREN WITH FIRST AFEBRILE SEIZURES: TO ORDER OR NOT TO ORDER?

455

Neuroimaging in chronic fatigue syndrome

456

Neuroimaging in communication sciences and disorders: An introduction

457

Neuroimaging in Iran: A Review

458

Neuroimaging in ophthalmology

459

Neuroimaging in Outpatients with Tension Type Headache

460

Neuroimaging in Pediatric Optic Neuritis: A Narrative Review

461

Neuroimaging in psychiatry: an update

462

Neuroimaging in sexual offenses and paraphilia: A call to harmonize current clinical and imaging assessments in sexual offenses and paraphilia

463

Neuroimaging of emotion and personality: Scientific evidence and ethical considerations

464

Neuroimaging of Higher Cognitive Function

465

Neuroimaging of interval timing

466

Neuroimaging of Performance Monitoring: Error Detection and Beyond

467

Neuroimaging on delayed postanoxic encephalopathy with lesions localized in basal ganglia

468

NEUROIMAGING OUTCOMES IN CLINICAL TRIALS IN ALZHEIMER’S DISEASE

469

Neuroimaging research and the neurobiology of obsessive–compulsive disorder: where do we go from here?

470

Neuroimaging resolution of the altered state hypothesis

471

Neuroimaging studies in Rett syndrome

472

Neuroimaging studies of delirium: A systematic review

473

Neuroimaging studies of mood disorder effects on the brain

474

Neuroimaging studies of mood disorders

475

Neuroimaging studies of obsessive–compulsive disorder in adults and children

476

Neuroimaging studies of practice-related change: fMRI and meta-analytic evidence of a domain-general control network for learning

477

Neuroimaging studies of psychological interventions for mood and anxiety disorders: Empirical and methodological review

478

Neuroimaging studies of speech: An overview of techniques and methodological approaches

479

Neuroimaging studies of the cerebellum: language, learning and memory

480

Neuroimaging study of myotonic dystrophy. I. Magnetic resonance imaging of the brain

481

Neuroimaging study of myotonic dystrophy. II. MRI measurements of the brain

482

Neuroimaging techniques offer new perspectives on callosal transfer and interhemispheric communication

483

Neuroimaging, the ischaemic penumbra, and selection of patients for acute stroke therapy

484

Neuroimaging, Uncertainty, and the Problem of Dispositions

485

Neuroimaging, Volume I Basic Science; Volume II Clinical Applications, , : edited by Erin D. Bigler, New York: Plenum Press, 1996, Volume I, 342 pp. and Volume II, 365 pp.

486

Neuroimaging. Cambridge medical reviews — neurobiology and psychiatry, vol. 3

487

NEURO-IMAGING: STRUCTURAL AND FUNCTIONAL IMAGING

488

Neuroimaging-based approaches in the brain–computer interface

489

Neuroimaging-based markers of bipolar disorder: Evidence from two meta-analyses

490

Neuroimmune and cortisol changes in selective serotonin reuptake inhibitor and placebo treatment of chronic posttraumatic stress disorder

491

Neuroimmune appendicitis Original Research Article

492

Neuroimmune appendicitis, peptides, and schizophrenia

493

Neuro-immune connection in spread of prions in the body?

494

Neuro-immune connections: evidence for a neuro-immunological synapse

495

Neuro-immune interactions in the lung

496

Neuroimmune networks and communication pathways: the importance of location

497

Neuroimmune response and sleep studies after whole body irradiation with high-LET particles Original Research Article

498

Neuroimmunoendocrine circuitry of the ‘brain-skin connection’

499

Neuroimmunology of the paraneoplastic neurological degenerations

500

Neuroimmunotoxic Effects of Occupational Exposure to Lead and Mercury

501

Neuroinfections: celebrating the past, discussing the present

502

Neuroinflammation and Alzheimer’s disease: critical roles for cytokine/Aβ-induced glial activation, NF-κB, and apolipoprotein E

503

Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease

504

Neuroinflammation in Autism Spectrum Disorders: the Role of High Mobility Group Box 1 Protein

505

Neuroinflammation in multiple sclerosis: Evidence for autoimmune dysregulation, not simple autoimmune reaction

506

Neuroinflammation: Implications for the Pathogenesis and Molecular Diagnosis of Alzheimerʹs Disease

507

Neuroinflammatory processes are important in neurodegenerative diseases: an hypothesis to explain the increased formation of reactive oxygen and nitrogen species as major factors involved in neurodegenerative disease development

508

Neuroinflammatory State of Multiple Sclerosis and Strategies for Biotherapeutics Development

509

Neuroinformatics Research for Vision Science: NRV project

510

Neuroinformatics: A new tool for studying the brain

511

Neurointensive care unit system for continuous electrophysiological monitoring with remote web-based review

512

Neuroinvasion by Chandipura virus

513

Neurokinin B peptide serum levels are higher in normotensive pregnant women than in preeclamptic pregnant women

514

Neurokinin-1 receptor expression in the mature dental pulp of rats

515

Neurokinin-1 receptors in the cerebrovascular vasoactive intestinal polypeptide-containing nerves in the rat

516

Neurolathyrism in Ethiopia: assessment and comparison of knowledge and attitude of health workers and rural inhabitants

517

Neurolaw and consciousness detection

518

Neurolaw: A brief introduction.

519

Neuroleptic binding to sigma receptors: Possible involvement in neuroleptic-induced acute dystonia

520

Neuroleptic discontinuation in clinical and research settings: scientific issues and ethical dilemmas

521

Neuroleptic drug exposure and treatment of parkinsonism in the elderly: A case-control study

522

Neuroleptic Malignant Syndrome

523

Neuroleptic Malignant Syndrome (NMS) on Clozapine with aPotential Atypical Interaction with Paliperidone

524

Neuroleptic malignant syndrome after venlafaxine

525

Neuroleptic malignant syndrome after venlafaxine

526

Neuroleptic malignant syndrome after venlafaxine Original Research Article

527

Neuroleptic malignant syndrome and catatonia: One entity or two?

528

Neuroleptic malignant syndrome and catatonia: One entity or two?

529

Neuroleptic malignant syndrome associated with nortriptyline

530

Neuroleptic malignant syndrome in a burn patient

531

Neuroleptic malignant syndrome in the burns patient?

532

Neuroleptic Malignant Syndrome Revisited in the Perspective of Pakistan

533

Neuroleptic malignant syndrome with gangliosidosis type II

534

Neuroleptic malignant-like syndrome in an elderly patient caused by abrupt withdrawal of tolcapone, a catechol-O-methyl transferase inhibitor

535

Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimerʹs disease

536

Neuroleptic sensitivity to risperidone in Lewy body dementia

537

Neuroleptic treatment and caudate plasticity

538

Neuroleptic-induced akathisia and early onset tardive dyskinesia in affective disorder due to Cushingʹs syndrome

539

Neuroleptic-induced tardive dyskinesia among Arab psychotic patients

540

Neuroleptics in progressive structural brain abnormalities in psychiatric illness

541

Neuroleptiques et sujet âgé

542

Neuro-levelset system based segmentation in dynamic susceptibility contrast enhanced and diffusion weighted magnetic resonance images

543

Neuroligin Expressed in Nonneuronal Cells Triggers Presynaptic Development in Contacting Axons

544

Neuro-linguistic approach to pattern recognition

545

Neurolinguistic aspects of attrition

546

Neurolinguistic Programming (NLP) and Transformational Leadership: A Conceptual Model for Malaysian Women Leader and Representative

547

NEUROLINGUISTIC PROGRAMMING (NLP): ITS OVERVIEW AND REVIEW IN THE LENSES OF PHILOSOPHY AND PEDAGOGY

548

Neurolinguistics. An Introduction to Spoken Language Processing and its Disorders, John Ingram. Cambridge University Press, Cambridge (Cambridge Textbooks in Linguistics) (2007)

549

Neurologic and developmental disability after extremely preterm birth

550

Neurologic and otologic findings in Fisherʹs syndrome

551

Neurologic complications after graft replacement of the entire thoracoabdominal aorta

552

Neurologic complications after total shoulder arthroplasty

553

Neurologic complications including paralysis after a medication error involving implanted intrathecal catheters

554

Neurologic complications of coronary artery bypass grafting: Diffuse or focal ischemia?

555

Neurologic Complications of Methanol Poisoning: A Clinicoepidemiological Report from Poisoning Treatment Centers in Tehran, Iran

556

Neurologic complications of surgery for anterior shoulder instability

557

Neurologic complications of the Novacor left ventricular assist device

558

Neurologic disease and vitamin B12 deficiency

559

Neurologic Diseases Associated with Use of Plant Components with Toxic Potential

560

Neurologic drug-psychotropic drug update

561

Neurologic events after coronary bypass grafting: Further observations with warm cardioplegia

562

Neurologic exam

563

Neurologic Examination Abnormalities in Children with Bipolar Disorder or Attention-Deficit/Hyperactivity Disorder

564

Neurologic feature of horizontal gaze paly and progreive colioi with mutation in ROBO3

565

Neurologic infections in a Nigerian university teaching hospital

566

Neurologic injury in cardiac surgical patients with a history of stroke

567

NEUROLOGIC MANIFESTATION OF ORGANIC ACADEMIA

568

Neurologic manifestations and treatment of Henoch–Schönlein purpura

569

Neurologic manifestations in patients with COVID-19: A case report

570

Neurologic Manifestations in Staphylococcus aureus Endocarditis: A Review of 260 Bacteremic Cases in Nondrug Addicts

571

Neurologic Manifestations of Childhood Rheumatic Diseases

572

Neurologic Monitoring on Cardiopulmonary Bypass: What Are We Obligated to Do?

573

Neurologic outcome after thoracic and thoracoabdominal aortic aneurysm repair

574

Neurologic outcome in octogenarians after aortic arch repair with hypothermic circulatory arrest

575

Neurologic outcome in patients with MRI pattern of damage typical for neonatal hypoglycemia

576

Neurologic Presentations of COVID-19: A Case Series

577

Neurologic Preservation by Na+-H+ Exchange Inhibition Prior to 90 Minutes of Hypothermic Circulatory Arrest

578

Neurologic Sequelae Associated With Deep Hypothermic Circulatory Arrest

579

Neurologic sequelae of deep hypothermic circulatory arrest in cardiac transplant infants

580

Neurologic signs and mobility limitations: a neglected link in the elderly

581

Neurologic soft signs and low birthweight: their association and neuropsychiatric implications

582

Neurological Abnormalities in Schizophrenic Twins

583

Neurological adverse event after administration of the hepatitis A vaccine

584

NEUROLOGICAL AND NEUROPSYCHIATRIC SPECTRUM OF WILSON S DISEASE IN LOCAL POPULATION

585

Neurological and neuropsychological characteristics of occipital, occipito-temporal and occipito-parietal infarction

586

Neurological and neuropsychological signs in obsessive compulsive disorder: interaction with behavioural treatment

587

NEUROLOGICAL AND OTHER MANIFESTATIONS OF WILSON DISEASE; 1998-2005

588

Neurological and psychological sequelae in transplant recipients after bridging with the bioartificial liver

589

Neurological and Vascular Manifestations of Ethylmalonic Encephalopathy

590

Neurological artform

591

Neurological aspects of hair growth

592

Neurological aspects of multiple myeloma and related disorders

593

Neurological aspects of spinal-cord repair: promises and challenges

594

Neurological aspects of the Angelman syndrome

595

Neurological bases for balance–anxiety links

596

Neurological bases of behavioral development in infancy

597

Neurological basis of skill learning

598

Neurological cases for experts only!

599

Neurological comorbidity affects prognosis in left ventricular hypertrabeculation/noncompaction

600

Neurological Complication of Infective Endocarditis Misdiagnosing with Multiple Sclerosis: A Case Report

601

Neurological complications and Japanese encephalitis vaccination

602

Neurological Complications Following Percutaneous Coronary Interventions (A Report from the 2000–2001 New York State Angioplasty Registry)

603

Neurological complications in heparin-induced thrombocytopenia

604

Neurological complications in renal failure: a review

605

Neurological complications in β-thalassemia

606

Neurological Complications of Corona Virus: A Mini-Review

607

Neurological complications of HIV infection

608

Neurological complications of HIV infection

609

Neurological Compromise Associated With COVID-19 Is Broader Than Anticipated Comment on “COVID-19 Pandemic and Neurological Disease: A Critical Review of the Existing Literature”

610

Neurological Crises after Discontinuation of Nitisinone (NTBC) Treatment in 3 Cases of Tyrosinemia

611

Neurological deficit as the first manifestation of vesical transitional cell carcinoma

612

neurological deficit following combined spinal-Epidural Anesthesia for knee arthroplasty

613

Neurological Disorders and Oxidative Toxic Stress: A Role of Metal Nanoparticles

614

Neurological disorders and the structure of human consciousness

615

Neurological disorders caused by inherited ion-channel mutations

616

Neurological Disorders due to Recurrent Hypoglycemia

617

Neurological disturbances due to filgrastim

618

Neurological Dysfunction in Elderly Patients Undergoing Coronary Artery Bypass Operation

619

Neurological effects of high-dose idebenone in patients with Friedreichʹs ataxia: a randomised, placebo-controlled trial

620

Neurological efficacy of stavudine, zidovudine, and lamivudine

621

Neurological efficacy of stavudine, zidovudine, and lamivudine

622

Neurological evaluation and intelligence testing in the child with operated congenital heart disease

623

Neurological Examination and Hearing Assessment of Premature Infants with Gestational Age of Less Than 32 Weeks at Follow-up

624

Neurological examination findings to predict limitations in mobility and falls in older persons without a history of neurological disease

625

Neurological finding of Mitochondrial Syndromes (MERRF and MELAS)

626

Neurological findings and outcome in adult cerebral malaria

627

Neurological Functions of CEO Investment based on Varimax Analysis and Rotated Matrix in Q Typology

628

Neurological gait disorders in elderly people: clinical approach and classification

629

NEUROLOGICAL IMPROVEMENT AFTER CERVICAL TRACTION IN PATIENTS WITH CERVICAL SPINE INJURY

630

Neurological infection

631

Neurological infection in The Lancet Neurology

632

Neurological infections: clinical advances and emerging threats

633

Neurological infections: clinical advances, global threats

634

Neurological Involvement of Patients with COVID-19: Proposed Neuroinvasive Mechanisms and Management

635

Neurological manifestation of coeliac disease with particular emphasis on gluten ataxia and immunological injury: a review article

636

Neurological Manifestation of COVID-19: A Literature Review

637

Neurological Manifestations and Risk Factors of HTLV-1 Infection in the Middle East Region and Iran: A Comprehensive Review of 137 Articles of the Last 23 Years

638

Neurological Manifestations and their Correlated Factors in COVID-19 Patients; a Cross-Sectional Study

639

Neurological Manifestations as Presenting Feature of Osteopetrosis in Children; A Review of 11 Cases

640

Neurological Manifestations in Critically Ill COVID-19 Patients

641

Neurological manifestations in patients with antiphospholipid syndrome.

642

NEUROLOGICAL MANIFESTATIONS OF ALLGROVE SYNDROME

643

Neurological Manifestations of an Old Disease: A Case Report

644

Neurological manifestations of Behçet’s disease

645

Neurological Manifestations of Celiac Disease

646

Neurological manifestations of dengue infection Original Research Article

647

Neurological manifestations of Ehlers-Danlos syndrome(s): A review.

648

Neurological manifestations of Hansenʹs disease and their management

649

Neurological Manifestations of Hospitalized COVID-19-Infected Patients: A Single-Center Cohort Study

650

Neurological manifestations of knockout mice with β-galactosidase deficiency

651

Neurological Manifestations of Patients Hospitalized with Coronavirus Disease 2019 in Babol, Iran

652

Neurological Manifestations of Renal Diseases in Children in Qazvin/ Iran

653

NEUROLOGICAL MANIFESTATIONS OF WILSONʹS DISEASE

654

Neurological manifestations, diagnosis, and treatment of celiac disease: A comprehensive review

655

Neurological Measurement of Human Trust in Automation Using Electroencephalogram

656

Neurological mechanisms of green tea polyphenols in Alzheimerʹs and Parkinsonʹs diseases

657

Neurological melioidosis

658

Neurological Monitoring and Off-Pump Surgery in a Very High-Risk Stroke Patient

659

Neurological outcome and S100 after coronary artery bypass grafting and abdominal aortic surgery

660

Neurological outcome following delayed fixation of unstable thoracolumbar spinal injuries with short segment posterior fixation

661

Neurological outcome of normothermic versus hypothermic cardiopulmonary bypass in simple congenital heart diseases

662

Neurological outcomes in coronary surgery: independent effect of avoiding cardiopulmonary bypass

663

Neurological presentation of Griscelli syndrome: Obstructive hydrocephalus without haematological abnormalities or organomegaly

664

Neurological presentation of three patients with 22q11 deletion (CATCH 22 syndrome)

665

Neurological presentations of nutritional vitamin B12 deficiency in 42 breastfed infants in Southeast Turkey

666

Neurological prognosis correlated with variations over time in the number of subependymal nodules in tuberous sclerosis

667

Neurological recovery in 80 cases of rapid stereotactic evacuation and local fibrinolysis in spontaneous hematomas of putamen and thalamus

668

Neurological Rehabilitation of Stroke Patients by Means of a Robotically Assisted Brain Controlled Interface

669

Neurological sequelae following a high voltage electrical burn

670

Neurological sequelae in children born after in-vitro fertilisation: a population-based study

671

Neurological sequelae in in-vitro fertilisation babies

672

Neurological sequelae in in-vitro fertilisation babies

673

Neurological sequelae in in-vitro fertilisation babies

674

Neurological sequelae in in-vitro fertilisation babies

675

Neurological sequelae of cerebral malaria

676

Neurological sequelae of cerebral malaria

677

Neurological Sequels and Their Causes in Patients Hospitalized in the Toxicology Intensive Care Unit of Bahraloo Hospital, Tehran, Iran

678

Neurological soft signs and response to risperidone in chronic schizophrenia

679

Neurological soft signs in bipolar I disorder patients

680

Neurological soft signs in schizophrenia: Are they related to negative or positive symptoms, neuropsychological performance, and violence?

681

Neurological soft signs, clinical symptoms and treatment reactivity in patients suffering from first episode schizophrenia

682

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder

683

Neurological Soft Signs: A Further Step in the Diagnosis of Bipolar-I Disorder?

684

Neurological Study of Radial Nerve Conduction During Endoscopic Radial Artery Harvesting:An Intra‐Operative Evaluation

685

Neurological Symptom in a Case of Adrenal Insufficiency

686

Neurological Symptoms as the First Presentation of Transitional Cell Carcinoma of Renal Pelvis

687

Neurological Wilson Disease in children: a three years experience from Multan

688

Neurologists are not immune

689

Neurologists determine the effect of migraine on quality of life

690

Neurologists give better stroke care

691

Neurologists say Florida woman is very unlikely to recover

692

693

Neurology elective at The Royal London Hospital

694

Neurology in sub-Saharan Africa—WHO cares?

695

Neurology of paediatric infectious diseases and immunodeficiency

696

Neurology of Touretteʹs syndrome (TS) TS as a developmental dopamine disorder: a hypothesis

697

Neurology of widely embedded free will

698

Neurology on the global health agenda

699

Neurology residency training in Europe: an Italian perspective

700

Neurology starters: simple to sublime

701

Neurology training around the world

702

Neurolymphomatosis as a single sign of tumor recurrence in a patient with diffuse large B-cell lymphoma of the testis

703

Neurolymphomatosis in Recrudescent Diffuse Large B-cell Lymphoma

704

Neurolymphomatosis of brachial plexus: A rare clinical presentation and the role of 18F-FDG PET/CT

705

Neuromagnetic activity in alpha and beta bands reflect learning-induced increases in coordinative stability

706

Neuromagnetic alpha suppression during an auditory Sternberg task: Evidence for a serial, self-terminating search of short-term memory

707

Neuromagnetic correlates of intra- and extra-dimensional set-shifting

708

Neuromagnetic effects on Anomalous Cognitive Experiences: A Critical Appraisal of the Evidence for Induced Sensed-presence and Haunt-type Experiences

709

Neuromagnetic imaging of cortical oscillations accompanying tactile stimulation

710

Neuromagnetic responses to vowels vs. tones reveal hemispheric lateralization

711

Neuromagnetic source localization of auditory evoked fields and intracerebral evoked potentials: a comparison of data in the same patients

712

Neuromarketing: beyond branding

713

Neuromarketing: Where marketing and neuroscience meet

714

Neuromedin B receptor antagonist suppresses tumor angiogenesis and tumor growth in vitro and in vivo

715

Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway

716

Neuromelanins in various regions of human brain are associated with native and oxidized isoprenoid lipids

717

Neurometabolic Diagnosis in Children who referred as Neurodevelopmental Delay (A Practical Criteria, in Iranian Pediatric Patients)

718

Neurometabolic Registry Site in Iran

719

720

Neuro-models for discharge air temperature system

721

Neuromodulation of parietal and motor activity affects motor planning and execution

722

Neuromodulation therapy does not influence blood flow distribution or left-ventricular dynamics during acute myocardial ischemia

723

Neuromodulation: acetylcholine and memory consolidation

724

Neuromodulation: An Overview

725

Neuromodulations of the Intractable Neurologic Symptoms

726

Neuromodulatory control of hippocampal function: towards a model of Alzheimer’s disease

727

Neuromodulatory role of Bacopa monnieri on oxidative stress induced by postnatal exposure to decabromodiphenyl ether (PBDE -209) in neonate and young female mice

728

Neuromodulatory unpaired median neurons in the New Zealand tree weta, Hemideina femorata

729

Neuromolecularware and its application to pattern recognition

730

Neuromonitoring and neurocognitive outcome in off-pump versus conventional coronary bypass operation

731

Neuromonitoring for awareness during surgery

732

Neuromonitoring of the external branch of the superior laryngeal nerve during thyroid surgery

733

Neuro-monte carlo solution of electrostatic problems

734

Neuromorbidity in preterm twins in relation to chorionicity and discordant birth weight

735

Neuromorphic implementation of orientation hypercolumns

736

Neuromorphic Synapses for Artificial Dendrites

737

Neuromotor control in stuttering: Speech, orofacial nonspeech, and finger movements

738

Neuromotor Issues in Human Performance: Introduction

739

Neuromotor Issues in the Learning and Control of Golf Skill

740

Neuro-mucormycosis: Lessons from COVID-19-associated cases

741

Neuromuscular Adjustments of the Quadriceps Muscle After Eccentric Resistance and Concentric Resistance Training

742

Neuromuscular and balance responses to flywheel inertial versus weight training in older persons

743

Neuromuscular and Blood Lactate Response After a Motocross Training Session in Amateur Riders

744

Neuromuscular and Metabolic Responses to Three Different Resistance Exercise Methods

745

Neuromuscular and psychomotor abnormalities in patients with schizophrenia and their first-degree relatives

746

Neuromuscular and spatial constraints on bimanual hand-held pendulum oscillations: Dissociation or combination?

747

Neuromuscular Blockade After Ingestion of Tree Tobacco (Nicotiana glauca), ,

748

Neuromuscular blockade as part of an anaesthetic protocol for cataract surgery in an alpaca

749

Neuromuscular Blockade, Bariatric Surgeon Satisfaction, and Quality of Patient Recovery

750

Neuromuscular Blocking Agent Use in Acute Respiratory Distress Syndrome: Which Variable is Important?

751

NEUROMUSCULAR BLOCKING AGENTS IN THE INTENSIVE CARE UNITS

752

Neuromuscular changes in a rat model of colitis

753

Neuromuscular Characteristics of Endurance- and Power-Trained Athletes

754

Neuromuscular consequences of prolonged hunger strike: an electrophysiological study

755

Neuromuscular Control and Coordination During Cycling

756

Neuromuscular control model of the arm including feedback and feedforward components

757

Neuromuscular disease laboratory

758

Neuromuscular diseases: therapeutic advances

759

Neuromuscular disorder in response to anterior cruciate ligament creep

760

Neuromuscular disorders in critical illness

761

Neuromuscular disorders: molecular and therapeutic insights

762

Neuromuscular disorders: orphan diseases deserve attention

763

Neuromuscular disorders: therapeutic advances

764

Neuromuscular dysfunction associated with delayed weaning from mechanical ventilation in patients with respiratory failure

765

NEUROMUSCULAR EFFECTS OF CISATRACURIUM IN MORBIDLY OBESE PATIENTS

766

Neuromuscular Electric Stimulation Versus Traditional Treatment on Harris Hip Score in Cases of Avascular Necrosis of Femoral Head After Kidney Transplantation

767

NEUROMUSCULAR ELECTRICAL STIMULATION OF MEDIUM an‎d LOW FREQUENCY ON THE QUADRICEPS FEMORIS

768

Neuromuscular Electrical Stimulation of the Cricothyroid Muscle in Patients With Suspected Superior Laryngeal Nerve Weakness

769

Neuromuscular excitability properties in myotonic dystrophy type 1

770

Neuromuscular function and bone density as independent predictors of fracture in older women: A 10-year longitudinal study

771

Neuromuscular implications in left ventricular hypertrabeculation/noncompaction

772

Neuromuscular mechanisms and anthropometric modifications in the initial stages of independent gait

773

Neuromuscular Mechanisms of Primary Peristalsis

774

Neuromuscular neutral zones response to cyclic lumbar flexion

775

Neuromuscular neutral zones response to static lumbar flexion: Muscular stability compensator

776

Neuromuscular neutral zones sensitivity to lumbar displacement rate

777

Neuromuscular objectives of the human masticatory apparatus during static biting

778

Neuromuscular Problems in the Patients With COVID-19: A Review Study

779

Neuromuscular recovery in ACL reconstruction with Bone-Tendon-Patellar-Bone and Semitendinosus-Gracilis autograft

780

Neuromuscular Retraining versus BTX-A Injection in Subjects with Chronic Facial Nerve Palsy, A Clinical Trial

781

Neuromuscular symptoms and dysfunction in subclinical hypothyroid patients: beneficial effect of L-T4 replacement therapy

782

Neuromuscular variables affecting the magnitude of force loss after eccentric exercise

783

Neuromuscular versus behavioural influences on reaching performance in young and elderly women

784

Neuromyelitis optica — Devicʹs syndrome, update

785

Neuromyelitis Optica and Nucleotide Variations of Aquaporin-4 Gene

786

Neuromyelitis optica in a patient with an early onset demyelinating episode: Clinical and autoantibody findings

787

Neuromyelitis optica in a pregnant woman with systemic lupus erythematous: A case report

788

Neuromyelitis Optica in Children: A Rare Entity

789

Neuromyelitis optica spectrum disease characteristics in Isfahan, Iran: A cross‑sectional study

790

Neuromyelitis optica: what it is and what it might be

791

792

Neuromyotonia, myocloni, sensory neuropathy and cerebellar symptoms in a patient with antibodies to neuronal nucleoproteins (anti-Hu-antibodies)

793

Neuromythology of Einstein’s brain

794

Neuron Cell Type-specific SNAP-25 Expression Driven by Multiple Regulatory Elements in the Nematode Caenorhabditis elegans

795

Neuron death due to unfolded protein response in gangliosidosis

796

Neuron death in ALS may be due to effects of neighbours

797

Neuron firing in driven nonlinear integrate-and-fire models

798

Neuron loss after coronary artery bypass detected by SPECT estimation of benzodiazepine receptors

799

Neuron loss in key cholinergic and aminergic nuclei in Alzheimer disease: a meta-analysis Review Article

800

Neuron Mathematical Model Representation of Neural Tensor Network for RDF Knowledge Base Completion

801

Neuron Numbers and Volume of the Amygdala in Subjects Diagnosed with Bipolar Disorder or Schizophrenia

802

Neuron source energy on resonance absorption

803

Neuronal activation and plasticity in Schistosoma mansoni infected mice

804

Neuronal activation in response to isoproterenol (Iso) in 6-day-old rat pups

805

Neuronal activity in the basal ganglia and thalamus in patients with dystonia

806

Neuronal and glial cell types revealed by NADPH-diaphorase histochemistry in the retina of a teleost fish, the grass goby (Zosterisessor ophiocephaluSy Perciformes, Gobiidae)

807

Neuronal and glial changes in the brain resulting from explosive blast in an experimental model

808

Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain

809

Neuronal and microglial cathepsins in aging and age-related diseases

810

Neuronal apoptosis linked to EglN3 prolyl hydroxylase and familial pheochromocytoma genes: Developmental culling and cancer

811

Neuronal Approach and the Use of KIK-NET Network to Generate Response Spectrum on the Surface

812

Neuronal assemblies: necessity, signature and detectability

813

Neuronal autoantibodies in focal epilepsy with or without mesial temporal sclerosis

814

Neuronal BC1 RNA: Microtubule-dependent Dendritic Delivery

815

Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease

816

Neuronal Cell Death in the Ischemic Spinal Cord: The Effect of Methylprednisolone

817

Neuronal cell death, nerve growth factor and neurotrophic models: 50 years on

818

Neuronal cell protective and antioxidant effects of phenolics obtained from Zanthoxylum piperitum leaf using in vitro model system

819

Neuronal Cell Reconstruction with Umbilical Cord Blood Cells in the Brain Hypoxia-Ischemia

820

Neuronal ceroid lipofuscinosis in a 31-year-old woman presenting as biventricular heart failure with restrictive features

821

Neuronal ceroid-lipofuscinosis: late infantile form or juvenile form?

822

Neuronal Changes in Normal Human Aging and Alzheimerʹs Disease

823

Neuronal circuitries involved in thermoregulation

824

Neuronal codes: reading them and learning how their structure influences network organization

825

Neuronal computers Original Research Article

826

Neuronal connections of the paratrigeminal nucleus: a topographic analysis of neurons projecting to bulbar, pontine and thalamic nuclei related to cardiovascular, respiratory and sensory functions

827

Neuronal contact guidance in magnetically aligned fibrin gels: effect of variation in gel mechano-structural properties

828

Neuronal Control of Metabolism through Nutrient-Dependent Modulation of Tracheal Branching

829

Neuronal correlates of “free will” are associated with regional specialization in the human intrinsic/default network

830

Neuronal Correlates of Colour-Graphemic Synaesthesia: Afmri Study

831

Neuronal correlates of context-related behavior

832

Neuronal Correlates of Obsessions in the Caudate Nucleus

833

Neuronal damage after hypothermic circulatory arrest and retrograde cerebral perfusion in the pig

834

Neuronal damage of the dorsal hippocampus induced by long-term right common carotid artery occlusion in rats

835

Neuronal death in the central nervous system during development

836

Neuronal degeneration and a decrease in laminin-like immunoreactivity is associated with elevated tissue-type plasminogen activator in the rat hippocampus after kainic acid injection

837

Neuronal differentiation modifies the effect of ethanol exposure on voltage-dependent calcium channels in NG 108-15 cells

838

Neuronal differentiation of induced pluripotent stem cells in hybrid polyester scaffolds with heparinized surface

839

Neuronal differentiation of mouse amnion membrane derived stem cells in response to neonatal brain medium

840

Neuronal Differentiation of Mouse Embryonic Stem Cells: Lineage Selection and Forced Differentiation Paradigms

841

Neuronal Differentiation of Rat Hair Follicle Stem Cells: the Involvement of the Neuroprotective Factor Seladin-1 (DHCR24)

842

Neuronal DNA damage correlates with overexpression of interleukin-1β converting enzyme in APPV717F mice

843

Neuronal effects of auditory distraction on visual attention

844

Neuronal Environment: the Brain Homeostasis in Health and Disease: W. Waltz, Humana Press, ISBN 0-89603-882-3, $145.00

845

Neuronal event detection in fMRI time series using iterative deconvolution techniques

846

Neuronal evolution: analysis of regulatory genes in a first-evolved nervous system, the hydra nervous system

847

Neuronal expression of Raf protooncogene in the brain stem of adult guinea pig

848

Neuronal feedback between brain and inner ear for growth of otoliths in fish Original Research Article

849

Neuronal firing activity in the dorsal hippocampus during the auditory discrimination oddball task in awake rats: relation to event-related potential generation

850

Neuronal function in chronic spinal cord injury: Divergence between locomotor and flexion- and H-reflex activity

851

Neuronal injury and death following focal mild brain injury: The role of network excitability and seizure

852

Neuronal Innervation, Intracellular Signal Transduction and Intercellular Coupling: a Model for Syncytial Tissue Responses in the Steady State

853

Neuronal Inputs from the Hypothalamus and Brain Stem to the Medial Preoptic Area of the Ram: Neurochemical Correlates and Comparison to the Ewe

854

Neuronal instability: implications for Rettʹs syndrome

855

Neuronal insulin signal transduction mechanisms in diabetes phenotypes

856

Neuronal intranuclear inclusion disease: neuropathologic study of a case

857

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

858

Neuronal kinase stimulation leads to aberrant tau phosphorylation and neurotoxicity

859

Neuronal lipofuscinosis

860

Neuronal loss and β-amyloid removal in the amygdala of people with Down syndromesmall star, filled

861

Neuronal loss in the colon of constipated Parkinsonʹs disease patients mimics that in the brain

862

Neuronal MAP2 mRNA: Species-dependent Differential Dendritic Targeting Competence

863

Neuronal maturation and N-acetyl-l-aspartic acid development in human fetal and child brains

864

Neuronal mechanisms mediating drug-induced cognition enhancement: cognitive activity as a necessary intervening variable

865

Neuronal Microtubule-associated Proteins: Insights into Their Structures and Functions

866

Neuronal migrational disorders in children with epilepsy: MRI, interictal SPECT and EEG comparisons

867

Neuronal nicotinic acetylcholine receptor binding affinities of boron-containing nicotine analogues

868

Neuronal nicotinic receptors and epilepsy, from genes to possible therapeutic compounds

869

Neuronal nicotinic receptors and ligands

870

Neuronal nitric oxide synthase (NNOS) catalyzes one-electron reduction of 2,4,6-trinitrotoluene, resulting in decreased nitric oxide production and increased nNOS gene expression: implication for oxidative stress

871

Neuronal nitric oxide synthase activity is increased during granulomatous inflammation in the colon and caecum of pigs infected with Schistosoma japonicum

872

Neuronal Nitric Oxide Synthase Expression in the Anterior Vaginal Wall of Patients with Stress Urinary Incontinence

873

Neuronal nitric oxide synthase gene transfer decreases [Ca2+]i in cardiac sympathetic neurons

874

Neuronal Nitric Oxide Synthase is Refractory to Mechanism-Based Inactivation in GH3Pituitary Cells

875

Neuronal Nitric Oxide Synthase–Membrane Phospholipid Interactions

876

Neuronal NO synthase (NOS1) is a major candidate gene for asthma

877

Neuronal nuclear antigen (NeuN): a marker of neuronal maturation in the early human fetal nervous system

878

Neuronal organization and cell interactions of the cat stellate ganglion

879

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging

880

Neuronal pathway from the liver modulates energy expenditure and systemic insulin sensitivity

881

Neuronal Phenomena Associated with Vigilance and Consciousness: From Cellular Mechanisms to Electroencephalographic Patterns,

882

Neuronal plasticity and survival in mood disorders

883

Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes

884

Neuronal porosome – The secretory portal at the nerve terminal: Its structure–function, composition, and reconstitution

885

Neuronal projections from ventral tegmental area to forebrain structures in rat studied by manganese-enhanced magnetic resonance imaging

886

Neuronal representations of cognitive state: reward or attention?

887

Neuronal stem cells: a tale of promise and caution

888

Neuronal Store-Operated Calcium Entry Pathway as a Novel Therapeutic Target for Huntingtonʹs Disease Treatment Original Research Article

889

Neuronal subpopulations and genetic background in tauopathies: a catch 22 story?

890

Neuronal subserving of behavior before and after chronic ethanol treatment

891

Neuronal substrates of sensory gating within the human brain

892

Neuronal substrates participating in attentional set-shifting of rules for visually guided motor selection: a functional magnetic resonance imaging investigation

893

Neuronal Subtype Specification within a Lineage by Opposing Temporal Feed-Forward Loops

894

Neuronal susceptibility to damage: comparison of the retinas of young, old and old/caloric restricted rats before and after transient ischemia

895

Neuronal synchrony detection on single-electron neural networks

896

Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Downʹs syndrome: a gene expression study

897

Neuronal toxicity of biopolymer-template synthesized ZnO nanoparticles

898

Neuronal, mesenchymal and hematopoietic cell derived from CD34− lin− cell from adult bone marrow

899

Neuronally-expressed necdin gene: an imprinted candidate gene in Prader-Willi syndrome

900

Neuronavigated repetitive transcranial magnetic stimulation in patients with tinnitus: a short case series

901

Neuronavigation assisted endoscopic sinus surgery

902

Neuronavigation for Intraoperative Localization of Cerebral Aneurysms

903

Neuronavigation for transcranial magnetic stimulation (TMS): Where we are and where we are going

904

Neuron-based VLSI architecture for real-time camera distortion correction

905

Neuron-controlled robots

906

Neuron-MOS Parallel Search Hardware for Real-Time Signal Processing

907

Neuronorm is a potent and water soluble neurokinin A receptor antagonist

908

Neurons and neuronal systems involved in the pathophysiologies of Rett syndrome

909

Neurons bearing neurofibrillary tangles are responsible for selected synaptic deficits in Alzheimerʹs disease

910

Neurons don’t represent

911

Neurons in amygdala mediate ear pinna vasoconstriction elicited by unconditioned salient stimuli in conscious rabbits

912

Neurons lose inhibitions in epilepsy

913

Neurons regenerate in absence of reactive astrocytes

914

Neurons, Cooperativity and the Role of Noise in Brain

915

Neurons, glia, and plasticity in normal brain aging

916

Neurons, viscose fluids, freshwater polyp hydra-and self-organizing information systems

917

Neuron-specific enolase and tau protein as neurobiochemical markers of neuronal damage are related to early clinical course and long-term outcome in acute ischemic stroke

918

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

919

Neuron-specific enolase antibodies in patients with sudden acquired retinal degeneration syndrome

920

Neuron-Specific enolase as a marker for acute ischemic stroke: A systematic review

921

Neuron-specific enolase as a marker of the severity and outcome of hypoxic ischemic encephalopathy

922

Neuron-specific enolase in cerebrospinal fluid as a neurochemical marker for brain damage in acute lymphoblastic leukemia

923

Neuron-specific enolase increases in plasma during and immediately after extracorporeal circulation

924

Neuron-specific enolase levels in the cerebrospinal fluid of neurologically healthy children

925

Neuron-specific enolase, nucleotides, nucleosides, purine bases, oxypurines and uric acid concentrations in cerebrospinal fluid of children with meningitis

926

Neuron-specific susceptibility to apolipoprotein E4

927

Neuron-synapse IC chip-set for large-scale chaotic neural networks

928

Neuron-tumor Interaction in Prostate Cancer: Implications and Future Perspective

929

Neuron-type polypyrrole device prepared by electrochemical polymerization method and its properties

930

Neuro-oncology for non-oncologists

931

Neuro-oncology for Nurses; Edited by Douglas Guerrero, Whur Publishers Ltd, £24.50

932

Neuro-oncology: diagnosis in the spotlight

933

Neuro-oncology: new insights and advances in treatment

934

Neuro-oncology: oligodendroglioma and molecular markers

935

Neuro-oncology: setting new standards of management

936

Neuro-oncology: the growing role of chemotherapy in glioma

937

Neuro-Ophthalmologic and Electroretinographic Finding in Pantothenate Kinae-Aociated Neurodegeneration (formerly Hallervorden-patz yndrome)

938

Neuro-Ophthalmologic Preentation of Hemicrania Continua

939

Neuro-ophthalmologic Recovery Following Endoscopic Endonasal Resection of Pituitary Macro-adenomas with Apoplexy

940

Neuro-ophthalmology review manual, revied 5th edition: Lanning B. Kline and Frank J. Bajanda. lack Incorporated: Thorofare, NJ; 2004.288 page$44.95 UDIBN 1-55642-672-0Media type: Review Manual

941

Neuro-Ophthalmology, The Requiite in Ophthalmology. Edited by Timothy J. Martin and Jame J. Corbett. t. Loui, Miouri, Moby Inc., 2000. Index, illutrated, 256 page. $89.00.

942

Neuro-ophthalmology: Neuronal Control of Eye Movements .A. Straube and U. Büttner Editors Basel Karger (2007).

943

Neuro-ophthalmology—Diagnoi and Management. Liu GT, Volpe NJ, Baletta L. New York, W.B. aunder, 2001. 756 page, index, illutrated. About $135.00

944

Neuro-optimal operation of a variable air volume HVAC&R system

945

Neuro-Optometry, Neuro-Optometrist, and Neuro-Optometric Rehabilitative Implications

946

Neuro-otologic Manifestations of Multiple Sclerosis

947

Neuro-otological features of Benign Paroxysmal Vertigo and Benign Paroxysmal Positioning Vertigo in children: A follow-up study

948

Neuropathic agents and pain. New strategies

949

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

950

Neuropathic arthropathy of the shoulder associated with syringomyelia: a report of six cases

951

Neuropathic diabetic patients do not have reduced variability of plantar loading during gait

952

Neuropathic elbow arthropathy: A review of six cases

953

Neuropathic gait shows only trends towards increased variability of sagittal plane kinematics during treadmill locomotion

954

Neuropathic injury to the levator ani occurs in 1 in 4 primiparous women

955

Neuropathic manifestations in rheumatoid arthritis : A clinical and electrophysiological assessment in a small sample of Iraqi patients.

956

Neuropathic Orofacial Pain: Proposed Mechanisms, Diagnosis, and Treatment Considerations

957

Neuropathic Osteoarthropathy in a Patient with Congenital Insensitivity to Pain

958

Neuropathic pain

959

NEUROPATHIC PAIN

960

Neuropathic pain

961

Neuropathic pain in hereditary coproporphyria

962

Neuropathic pain in soft tissue complaints

963

Neuropathic pain research pinpoints new role for microglia

964

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

965

Neuropathic Pain Treatment Gives Avigen New Lease on Life and Neuromed Follows the Snail Trail

966

Neuropathic Pain: A Review of Interneuronal Disinhibition

967

Neuropathic pain: aetiology, symptoms, mechanisms, and management

968

Neuropathic symptoms and findings in women with Fabry disease

969

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

970

Neuropathie radio-induite du nerf optique après traitement pour cancer du nasopharynx. ہ propos de deux cas et revue de la littérature

971

Neuropathies of the foot

972

Neuropathogenicity of Equine Herpesvirus 9 in Cattle

973

Neuropathologic study of long term cyanide administration to goats

974

Neuropathological alteration of aquaporin 1 immunoreactive enteric neurons in the streptozotocin-induced diabetic rats

975

Neuropathological analysis of the brainstem and cerebral cortex lesions on epileptogenesis in hereditary dentatorubral-pallidoluysian atrophy

976

Neuropathological assessment of artemether-treated severe malaria

977

Neuropathological Changes in Brain Cortex and Hippocampus in a Rat Model of Alzheimer’s Disease

978

NEUROPATHOLOGICAL CHANGES IN THE PDAPP TRANSGENIC MOUSE MODEL OF ALZHEIMER S DISEASE

979

Neuropathological characteristics and alteration of the dopamine D2 receptor in hypoxic-ischemic basal ganglia necrosis

980

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease

981

Neuropathological Criteria for the Diagnosis of Alzheimer’s Disease: Are We Really Ready Yet?

982

Neuropathological Diagnosis of Alzheimer’s Disease: A Perspective from Longitudinal Clinicopathological Studies

983

Neuropathological epidemiology of cerebral aging: a study of two genetic polymorphisms

984

Neuropathological findings in the cerebro-oculo-facio-skeletal (Pena-Shokeir II) syndrome

985

Neuropathological markers of impaired cognition in the entorhinal cortex

986

Neuropathological Staging of Alzheimer-Related Lesions: The Challenge of Establishing Relations to Age

987

Neuropathological studies of brain tissue in schizophrenia

988

Neuropathologies of the self: Clinical and anatomical features

989

Neuropathology and Genetics of Dementia, Edited by Tolnay M. and Probst A., Kluwer Academic/Plenum Publ., London, 2000.

990

Neuropathology in controls and demented subjects from the Baltimore longitudinal study of aging

991

Neuropathology of bipolar disorder

992

Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment

993

Neuropathology of developmental abnormalities

994

Neuropathology of early-infantile epileptic encephalopathy with suppression-bursts; comparison with those of early myoclonic encephalopathy and West syndrome

995

Neuropathology of mitral valve prolapse in man and cardiopulmonary bypass (CPB) surgery in adolescent Yorkshire pigs

996

Neuropathology of prion diseases

997

Neuropathology of the limbic system and brainstem in West syndrome

998

Neuropathology of tuberous sclerosis

999

Neuropathology of variant Creutzfeldt-Jakob disease

1000

Neuropathy complicating diffuse infiltrative lymphocytosis

بازگشت